Incentives for pharmaceutical innovation: What’s working, what’s lacking

Margaret K. Kyle

International Journal of Industrial Organization, 2022, vol. 84, issue C

Abstract: This article provides an overview of the performance of innovation policies in the pharmaceutical sector. It discusses the conditions under which various policies are mostly likely to result in socially valuable R&D. Interactions between different domestic policies, as well as the importance of considering strategic interactions between governments, are also highlighted.

Keywords: Innovation; Pharmaceuticals; Health; COVID (search for similar items in EconPapers)
Date: 2022
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
http://www.sciencedirect.com/science/article/pii/S0167718722000261
Full text for ScienceDirect subscribers only

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eee:indorg:v:84:y:2022:i:c:s0167718722000261

DOI: 10.1016/j.ijindorg.2022.102850

Access Statistics for this article

International Journal of Industrial Organization is currently edited by P. Bajari, B. Caillaud and N. Gandal

More articles in International Journal of Industrial Organization from Elsevier
Bibliographic data for series maintained by Catherine Liu ().